Mast cells in human allografted kidney: Correlation with interstitial fibrosis

Clinical Transplantation

Volumn 16, Issue SUPPL. 8, 2002, Pages 7-11

  Goto, Eizo ^a   Honjo, Soichiro ^a   Yamashita, Hideki ^a   Shomori, Kohei ^a   Adachi, Hironobu ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Human allografted kidney; Mast cell; Microvessels; Tryptase

Indexed keywords

CHYMASE; NAPHTHOL AS D ESTERASE; TOLONIUM CHLORIDE; TRYPTASE;

CHRONIC ALLOGRAFT NEPHROPATHY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY TRANSPLANTATION; MAST CELL; MICROVASCULATURE; NEPHRECTOMY; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ARTICLE; CELL COUNT; CHRONIC DISEASE; FIBROSIS; KIDNEY; KIDNEY DISEASE; MICROCIRCULATION; PATHOLOGY; POSTOPERATIVE COMPLICATION;

CELL COUNT; CHRONIC DISEASE; DIABETIC NEPHROPATHIES; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MAST CELLS; MICROCIRCULATION; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 18744405995     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.16.s8.1.x     Document Type: Conference Paper

References (33)

1. LEMSTROM K, KOSKINEN P, HARRY P. Molecular mechanisms of chronic renal allograft rejection. Kidney Int 1995: 52 (Suppl.): S2-S10.
2. BARTH C, VON MENGES A, ZANKER B, LAMMERDING P, STACHOWSKI J, BALDAMUS CA. Restricted T cell V beta repertoire in renal allografts during acute and chronic rejection. Kidney Int 1996: 50: 2020.
3. DODD SM. Chronic allograft nephropathy: the inevitable outcome of renal transplantation? Curr Top Pathol 1999: 92: 37.
4. SOLEZ K, AXELSEN RA, BENEDIKTSSON H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplantation pathology. Kidney Int 1993: 44: 411.
5. HAN Y-S, UEDA M, TANABE S et al. Immunocytochemical analysis of obliterative arteriopathy of human renal allografts. Transplant Proc 1994: 26: 931.
6. COLVIN RB, DVORAK HF. Basophils and mast cells in renal allograft rejection [Letter]. Lancet 1974: 1: 212.
7. COLVIN RB, DVORAK AM, DVORAK HF. Mast cells in the cortical tubular epithelium and interstitium in human renal disease. Hum Pathol 1974: 5: 315.
8. LAJOIE G, NADASDY T, LASZIK Z et al. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 1996: 9: 1118.
9. HORNY HP, RUCK P, XIAO JC, KAISERLING E. Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1. Hum Pathol 1993: 24: 355.
10. GORDON JR, BURD PR, GALLI SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990: 11: 458.
11. GALLI SJ. New concepts about the mast cell. N Engl J Med 1993: 328: 257.
12. SCHWARZ LB. Mast cell: function and contents. Curr Opin Immunol 1994: 6: 91.
13. GALLI SJ, WERSHIL BK. The two faces of the mast cell. Nature 1996: 381: 21.
14. HEBDA PA, COLLINS MA, THARP MD. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993: 11: 685.
15. ATKINSON JB, HARLAN CW, HARLAN GC, VIRMANI R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994: 25: 154.
16. DIMETRIADOU V, KOUTSILIERIS M. Mast cell-tumor cell interactions: for or against tumor growth and metastasis? Anticancer Res 1997: 17: 1541.
17. HIROMURA K, KUROSAWA M, YANO S, NARUSE T. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 1998: 32: 593.
18. EHARA T, SHIGEMATSU H. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 1998: 54: 1675.
19. RUGER BM, HASAN Q, GREENHILL NS, DAVIS PF, DUNBAR PR, NEALE TJ. Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 1996: 39: 1215.
20. LAJOIRE G, MADASDY T, LASZIK Z, BLICK KE, SILVA FG. Mast cells in acute cellular rejection of human renal allografts. Mod Pathol 1996: 9: 1118.
21. PARDO J, DIAZ L, ERRASTI P et al. Mast cells in chronic rejection of human renal allografts. Virchows Arch 2000: 437: 167.
22. IRANI AA, SCHECHTER NM, CRAIG SS, DEBLOIS G, SCHWARTZ LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986: 83: 4464.
23. YAMADA M, UEDA M, NARUKO T et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 2001: 59: 1374.
24. RACUSEN LC, SOLEZ K, COLVIN RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
25. ROBERTS IS, BRENCHLEY PE. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol 2000: 53: 858.
26. YOUSEM SA. The potential role of mast cells in lung allograft rejection. Hum Pathol 1997: 28: 179.
27. OKAZAKI T, HIROTA S, Xu ZD et al. Increase of mast cells in the liver and lung may be associated with but not acause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab Invest 1998: 78: 1431.
28. JONHNSON LL, DYER R, HUPE DJ. Matrix metalloproteinase. Curr Opin Chem Biol 1998: 2: 466.
29. CAIRNS JA, WALLS AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997: 99: 1313.
30. GRUBER BL, KEW RR, JELASKA A et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997: 158: 2310.
31. TRAUTMANN A, KROHNE G, BROCKER EB, KLEIN CE. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J Immunol 1998: 160: 5053.
32. CAIRNS JA, WALLS AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996: 156: 275.
33. BLAIR RJ, MENG H, MARCHESE MJ et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997: 99: 2691.